About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Reports Third Quarter 2026 Financial Results 11-04-2026 at 4:05 PM EST Adaptive Biotechnologies to Report Third Quarter 2026 Financial Results on November 4, 2026 10-14-2026 at 4:05 PM EDT Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure 09-25-2026 at 8:03 AM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies Third Quarter Financial Results Nov 4, 2026 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q3 2026 Earnings Presentation 623.5 KB Morgan Stanley 24th Annual Global Healthcare Conference Sep 15, 2026 at 4:50 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Jul 29, 2026 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q2 2026 Earnings Presentation 872.3 KB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Nov 5, 2026 12:35 AM ESTData Provided by Refinitiv. Minimum 15 minutes delayed.
